Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux - PubMed

Affiliations

• PMID: 11306694
• DOI: 10.1124/mol.59.5.1108

Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux

A J Smith et al. Mol Pharmacol. 2001 May.

Abstract

Inhibitory gamma-aminobutyric acid (GABA)(A) receptors are subject to modulation at a variety of allosteric sites, with pharmacology dependent on receptor subunit combination. The influence of different alpha subunits in combination with beta3gamma2s was examined in stably expressed human recombinant GABA(A) receptors by measuring (36)Cl influx through the ion channel pore. Muscimol and GABA exhibited similar maximal efficacy at each receptor subtype, although muscimol was more potent, with responses blocked by picrotoxin and bicuculline. Receptors containing the alpha3 subunit exhibited slightly lower potency. The comparative pharmacology of a range of benzodiazepine site ligands was examined, revealing a range of intrinsic efficacies at different receptor subtypes. Of the diazepam-sensitive GABA(A) receptors (alpha1, alpha2, alpha3, alpha5), alpha5 showed the most divergence, being discriminated by zolpidem in terms of very low affinity, and CL218,872 and CGS9895 with different efficacies. Benzodiazepine potentiation at alpha3beta3gamma2s with nonselective agonist chlordiazepoxide was greater than at alpha1, alpha2, or alpha5 (P < 0.001). The presence of an alpha4 subunit conferred a unique pharmacological profile. The partial agonist bretazenil was the most efficacious benzodiazepine, despite lower alpha4 affinity, and FG8205 displayed similar efficacy. Most striking were the lack of affinity/efficacy for classical benzodiazepines and the relatively high efficacy of Ro15-1788 (53 +/- 12%), CGS8216 (56 +/- 6%), CGS9895 (65 +/- 6%), and the weak partial inverse agonist Ro15-4513 (87 +/- 5%). Each receptor subtype was modulated by pentobarbital, loreclezole, and 5alpha-pregnan-3alpha-ol-20-one, but the type of alpha subunit influenced the level of potentiation. The maximal pentobarbital response was significantly greater at alpha4beta3gamma2s (226 +/- 10% increase in the EC(20) response to GABA) than any other modulator. The rank order of potentiation for pregnanolone was alpha5 > alpha2 > alpha3 = alpha4 > alpha1, for loreclezole alpha1 = alpha2 = alpha3 > alpha5 > alpha4, and for pentobarbital alpha4 = alpha5 = alpha2 > alpha1 = alpha3.

Similar articles

• Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.

  Whittemore ER, Yang W, Drewe JA, Woodward RM. Whittemore ER, et al. Mol Pharmacol. 1996 Nov;50(5):1364-75. Mol Pharmacol. 1996. PMID: 8913369

• Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.

  Wafford KA, Bain CJ, Whiting PJ, Kemp JA. Wafford KA, et al. Mol Pharmacol. 1993 Aug;44(2):437-42. Mol Pharmacol. 1993. PMID: 8102787

• Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

  Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA. Brown N, et al. Br J Pharmacol. 2002 Aug;136(7):965-74. doi: 10.1038/sj.bjp.0704795. Br J Pharmacol. 2002. PMID: 12145096 Free PMC article.

• GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.

  Atack JR. Atack JR. Curr Top Med Chem. 2011;11(9):1203-14. doi: 10.2174/156802611795371314. Curr Top Med Chem. 2011. PMID: 21050171 Review.

• Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.

  Atack JR. Atack JR. Curr Drug Targets CNS Neurol Disord. 2003 Aug;2(4):213-32. doi: 10.2174/1568007033482841. Curr Drug Targets CNS Neurol Disord. 2003. PMID: 12871032 Review.

Cited by

• Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.

  Varagic Z, Wimmer L, Schnürch M, Mihovilovic MD, Huang S, Rallapalli S, Cook JM, Mirheydari P, Ecker GF, Sieghart W, Ernst M. Varagic Z, et al. Br J Pharmacol. 2013 May;169(2):371-83. doi: 10.1111/bph.12151. Br J Pharmacol. 2013. PMID: 23472852 Free PMC article.

• Negative GABA(A) modulators attenuate the discriminative stimulus effects of benzodiazepines and the neuroactive steroid pregnanolone in rhesus monkeys.

  McMahon LR, France CP. McMahon LR, et al. Psychopharmacology (Berl). 2005 Oct;181(4):697-705. doi: 10.1007/s00213-005-0028-1. Epub 2005 Sep 29. Psychopharmacology (Berl). 2005. PMID: 15983789

• Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.

  Hambrecht-Wiedbusch VS, Gauthier EA, Baghdoyan HA, Lydic R. Hambrecht-Wiedbusch VS, et al. Sleep. 2010 Jul;33(7):909-18. doi: 10.1093/sleep/33.7.909. Sleep. 2010. PMID: 20614851 Free PMC article.

• Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

  Varagic Z, Ramerstorfer J, Huang S, Rallapalli S, Sarto-Jackson I, Cook J, Sieghart W, Ernst M. Varagic Z, et al. Br J Pharmacol. 2013 May;169(2):384-99. doi: 10.1111/bph.12153. Br J Pharmacol. 2013. PMID: 23472935 Free PMC article.

• Modulating GABA modulators.

  Paronis CA. Paronis CA. Br J Pharmacol. 2006 Feb;147(3):237-8. doi: 10.1038/sj.bjp.0706552. Br J Pharmacol. 2006. PMID: 16331288 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database